Share-based Payment Arrangement, Expense of Mind Medicine (MindMed) Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Mind Medicine (MindMed) Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Mind Medicine (MindMed) Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $5,816,000, a 51% increase year-over-year.
  • Mind Medicine (MindMed) Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $18,448,000, a 13% increase year-over-year.
  • Mind Medicine (MindMed) Inc. annual Share-based Payment Arrangement, Expense for 2024 was $16,913,000, a 11% increase from 2023.
  • Mind Medicine (MindMed) Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15,183,000, a 11% increase from 2022.
  • Mind Medicine (MindMed) Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13,707,000, a 68% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Mind Medicine (MindMed) Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $18,448,000 $5,816,000 +$1,975,000 +51% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $16,473,000 $5,253,000 -$177,000 -3.3% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $16,650,000 $3,426,000 -$263,000 -7.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $16,913,000 $3,953,000 +$588,000 +17% 01 Oct 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q3 2024 $16,325,000 $3,841,000 -$385,000 -9.1% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $16,710,000 $5,430,000 +$1,588,000 +41% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 $15,122,000 $3,689,000 -$61,000 -1.6% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $15,183,000 $3,365,000 +$1,989,000 +145% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $13,194,000 $4,226,000 -$60,000 -1.4% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $13,254,000 $3,842,000 -$411,000 -9.7% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $13,665,000 $3,750,000 -$42,000 -1.1% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $13,707,000 $1,376,000 -$2,968,000 -68% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $16,675,000 $4,286,000 +$181,000 +4.4% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $16,494,000 $4,253,000 -$28,735,000 -87% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $45,229,000 $3,792,000 +$2,513,000 +196% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $42,716,000 $4,344,000 01 Oct 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $4,105,000 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $32,988,000 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $1,279,000 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1

Mind Medicine (MindMed) Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $16,913,000 +$1,730,000 +11% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
2023 $15,183,000 +$1,476,000 +11% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $13,707,000 -$29,009,000 -68% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
2021 $42,716,000 +$35,310,000 +477% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $7,406,000 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.